Search

Your search keyword '"Cameron DR"' showing total 129 results

Search Constraints

Start Over You searched for: Author "Cameron DR" Remove constraint Author: "Cameron DR"
129 results on '"Cameron DR"'

Search Results

2. Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

4. The influence of model frameworks in spatial planning of regional climate-adaptive connectivity for conservation planning

5. Hyperosmotic Infusion and Oxidized Surfaces Are Essential for Biofilm Formation of Staphylococcus capitis From the Neonatal Intensive Care Unit

6. Systems analysis. (Work at Height)

8. Staff Ride Handbook For The Battle Of Perryville, 8 October 1862 [Illustrated Edition]

9. Identification of a Class of Protein ADP-Ribosylating Sirtuins in Microbial Pathogens

11. Antibiotic regimen based on population analysis of residing persister cells eradicates Staphylococcus epidermidis biofilms

12. Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56lck SH2 domain

15. Potent β-Lactam Inhibitors of Human Cytomegalovirus Protease

17. Book ReviewsDetailed guide to research for the novice Nursing research: principles, process and issues K Parahoo, Macmillan, Basingstoke, 1997 Pp 403 Price £14.99 ISBN 0 333 699181Assessing the needs of the community Needs to Know: a guide to needs assessment for primary care Edited by Andrew Harris FT Healthcare, 1997 Pp 160 Price £21.50 ISBN 0 443 0 05569 6Protocol guide leaves out nurses' view The Minor Illness Manual Gina Johnson, Ian Hill-Smith and Chris Ellis Radcliffe Medical Press 1977 Pp 109 Price £12.95 ISBN 1 85775 285 6

19. 'The Apparent Mid Zone Pneumatocele in the Intensive Care Patient'.

22. TOUGH Grasses.

23. Model-based translation of results from in vitro to in vivo experiments for afabicin activity against Staphylococcus aureus.

24. BET-inhibitor DYB-41 reduces pulmonary inflammation and local and systemic cytokine levels in LPS-induced acute respiratory distress syndrome: an experimental rodent study.

25. Virulence attributes of successful methicillin-resistant Staphylococcus aureus lineages.

26. Natural climate solutions provide robust carbon mitigation capacity under future climate change scenarios.

27. Dynamics of bacterial pathogens at the driveline exit site in patients with ventricular assist devices: A prospective, observational, single-center cohort study.

28. Evaluation of the microbiota-sparing properties of the anti-staphylococcal antibiotic afabicin.

29. Ten-year retrospective cohort analysis of ventricular assist device infections.

30. A resilient and connected network of sites to sustain biodiversity under a changing climate.

31. Parallel Evolution of Pseudomonas aeruginosa during a Prolonged ICU-Infection Outbreak.

32. Accuracy, realism and general applicability of European forest models.

33. Efficacy of phage therapy in preclinical models of bacterial infection: a systematic review and meta-analysis.

34. Mutation to ispA Produces Stable Small-Colony Variants of Pseudomonas aeruginosa That Have Enhanced Aminoglycoside Resistance.

35. Development and early diagnosis of critical illness myopathy in COVID-19 associated acute respiratory distress syndrome.

36. Efficacy assessment of a novel endolysin PlyAZ3aT for the treatment of ceftriaxone-resistant pneumococcal meningitis in an infant rat model.

37. Benefits of Aerosolized Phages for the Treatment of Pneumonia Due to Methicillin-Resistant Staphylococcus aureus: An Experimental Study in Rats.

38. Increasing taxonomic diversity and spatial resolution clarifies opportunities for protecting US imperiled species.

39. "No-regrets" pathways for navigating climate change: planning for connectivity with land use, topography, and climate.

40. Searching for synergy: combining systemic daptomycin treatment with localised phage therapy for the treatment of experimental pneumonia due to MRSA.

41. Is myopathy part of long-Covid?

42. Towards robust statistical inference for complex computer models.

43. Isolation and characterization of bacteriophages from the human skin microbiome that infect Staphylococcus epidermidis .

44. Progress and Pitfalls of Bacteriophage Therapy in Critical Care: A Concise Definitive Review.

45. Bacterial persisters in long-term infection: Emergence and fitness in a complex host environment.

46. Defense mechanisms to increasing back pressure for hepatic oxygen transport and venous return in porcine fecal peritonitis.

47. Nebulized Bacteriophages for Prophylaxis of Experimental Ventilator-Associated Pneumonia Due to Methicillin-Resistant Staphylococcus aureus.

48. Hyperosmotic Infusion and Oxidized Surfaces Are Essential for Biofilm Formation of Staphylococcus capitis From the Neonatal Intensive Care Unit.

49. Bacteriophages Improve Outcomes in Experimental Staphylococcus aureus Ventilator-associated Pneumonia.

Catalog

Books, media, physical & digital resources